LIN, Chenyi. Clinical Evaluation of Bexagliflozin and Other SGLT2 Inhibitors for Type 2 Diabetes Management. Highlights in Science, Engineering and Technology, [S. l.], v. 74, p. 1576–1580, 2023. DOI: 10.54097/zzqmbq95. Disponível em: https://drpress.org/ojs/index.php/HSET/article/view/15871. Acesso em: 1 aug. 2026.